Literature DB >> 10780497

Inter-species consistency in the behavioural pharmacology of nicotine dependence.

I P Stolerman1.   

Abstract

Studies on the dependence-related behavioural effects of nicotine in animals and humans have been compared to assess the extent of inter-species consistency in relation to the face, construct and predictive validity of the animal models. The major areas covered in this selective review are neuroadaptations occurring as a consequence of repeated exposures to nicotine (i.e. tolerance, sensitization and withdrawal) and the stimulus properties of nicotine (positively reinforcing, discriminative stimulus and aversive stimulus effects). Most of these phenomena were demonstrated first in animal subjects, often many years before comparable data for humans became available, although this was not invariably the case. It is argued that the overall pattern of results for the neuroadaptations is very similar across species. More specifically, it is proposed that repeated exposure to nicotine produces a change from a relatively aversive initial overall profile to one in which tolerance has developed to the aversive effects and the positive effects on mood have been enhanced or sensitized; at the same time a withdrawal syndrome develops that can now be assessed by a variety of measures in animal and human subjects. With regard to stimulus properties, the nicotine discriminative stimulus in animal and human subjects shows a particularly close correspondence, which may reflect the functional equivalence of the procedures in the different species. The self-administration of pure nicotine, as contrasted with tobacco smoke, has been firmly established in animal subjects for some time but there are only a small number of strictly comparable studies in humans. Both differences and similarities in findings across species may be seen; however, care must be taken to identify the possible confounding influence of procedural variation between species, rather than the species per se, as the determining factor. Overall, the animal studies in this area have shown remarkably good predictive validity, coupled with rather more variable levels of face and construct validity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10780497     DOI: 10.1097/00008877-199911000-00002

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  15 in total

1.  Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.

Authors:  Karen L Skjei; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-24       Impact factor: 4.530

2.  Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and self-administered nicotine doses and serum concentrations.

Authors:  Mark G LeSage; Daniel E Keyler; Greg Collins; Paul R Pentel
Journal:  Psychopharmacology (Berl)       Date:  2003-07-25       Impact factor: 4.530

Review 3.  Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.

Authors:  Mark G LeSage; Daniel E Keyler; Paul R Pentel
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

4.  Nicotine as a typical drug of abuse in experimental animals and humans.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2005-10-05       Impact factor: 4.530

Review 5.  Behavioral mechanisms underlying nicotine reinforcement.

Authors:  Laura E Rupprecht; Tracy T Smith; Rachel L Schassburger; Deanne M Buffalari; Alan F Sved; Eric C Donny
Journal:  Curr Top Behav Neurosci       Date:  2015

6.  Assessing Discrimination of Nicotine in Humans Via Cigarette Smoking.

Authors:  Kenneth A Perkins; Nicole Kunkle; Valerie C Michael; Joshua L Karelitz; Eric C Donny
Journal:  Nicotine Tob Res       Date:  2016-03-24       Impact factor: 4.244

7.  Acquired appetitive responding to intravenous nicotine reflects a Pavlovian conditioned association.

Authors:  Jennifer E Murray; Rick A Bevins
Journal:  Behav Neurosci       Date:  2009-02       Impact factor: 1.912

Review 8.  Effects of nicotine in experimental animals and humans: an update on addictive properties.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Handb Exp Pharmacol       Date:  2009

9.  Individual differences in responses to nicotine: tracking changes from adolescence to adulthood.

Authors:  Ming Li; Alexa Mead; Rick A Bevins
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

10.  Partial nicotinic acetylcholine (alpha4beta2) agonists as promising new medications for smoking cessation.

Authors:  J Singh; Salil Budhiraja
Journal:  Indian J Pharmacol       Date:  2008-10       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.